 |
| CLENIL |
For The Medical Profession Only Beclomethasone dipropionate
+Salbutamol (CLENIL)® Compositum Spray
Each Bottle Contains
Beclomethasone -17,21 dipropionate 0.010 g
Salbutamol 0.020 g
(CLENIL) The container is equivalent to 200 metered inhalations
Each inhalation releases 50 Meg. of beclomethasone dipropionate and 100 meg. of salbutamol
PROPERTIES: Clenil Compositum Spray is a combination of a bronehodilator, salbutamol, with an active corticosteroid for inhalation beclomethasone dipropionate.
Salbutamol is characterised by a rapid and persistent bronchial antispastic action which produces a prompt improvement of the respiratory function.
Salbutamol acts selectively at the level of the bronchial musculature without giving undesirable cardiocirculatory effects.
On the other hand, beclometbasone dipropionate controls bronchial hyperactivity reducing oedema and hypersecretion and inhibiting Progressively the onset of bronchospasm. The activity of beclomethasone dipropionate is limited to the bronchial tree without causing general effects and therefore without inhibiting adrenal function.
In Clenil Compositum Spray, the actions of the two active substances complete and potentiate one another, thus providing both treatment for the acute asthmatic patients and maintenance therapy for astluna and asthmatic bronchitis to prevent and to diminish the frequency of the asthmatic attacks.
In order to reach full therapeutic success, it is important for the patient to accurately follow the instructions and to correctly use the inhaler.
INDICATIONS: Bronchial asthma, asthmatic bronchitis, chronic bronchitis and emphysema with a broncho - spastic component.
DOSAGE:
Adults: two puffs four to six times a day.
Children: under 12 years of age: one - two puffs two - four times a day. according to therapeutic effect.
the effect of the inhalation of Clenil Compositum Spray persists for at least four hours. No more than two puffs at a time should be employed and the treatment should not be repeated before four hours.
SIDE EFFECTS: No serious side effect has been revealed due to the use of clenil Compositum Spray at recommended doses, only some patients have complained of hoarseness. In some patients local fungal infection have appeared in the mouth and throat, they rapidly disappear with appropriate local therapy of antimycotics without interruption of treatment. Transitory side effects can appear at high dosages in some patients (moderate increase of cardiac frequency, light muscular tremor)
+Salbutamol (CLENIL)® Compositum Spray
Each Bottle Contains
Beclomethasone -17,21 dipropionate 0.010 g
Salbutamol 0.020 g
(CLENIL) The container is equivalent to 200 metered inhalations
Each inhalation releases 50 Meg. of beclomethasone dipropionate and 100 meg. of salbutamol
PROPERTIES: Clenil Compositum Spray is a combination of a bronehodilator, salbutamol, with an active corticosteroid for inhalation beclomethasone dipropionate.
Salbutamol is characterised by a rapid and persistent bronchial antispastic action which produces a prompt improvement of the respiratory function.
Salbutamol acts selectively at the level of the bronchial musculature without giving undesirable cardiocirculatory effects.
On the other hand, beclometbasone dipropionate controls bronchial hyperactivity reducing oedema and hypersecretion and inhibiting Progressively the onset of bronchospasm. The activity of beclomethasone dipropionate is limited to the bronchial tree without causing general effects and therefore without inhibiting adrenal function.
In Clenil Compositum Spray, the actions of the two active substances complete and potentiate one another, thus providing both treatment for the acute asthmatic patients and maintenance therapy for astluna and asthmatic bronchitis to prevent and to diminish the frequency of the asthmatic attacks.
In order to reach full therapeutic success, it is important for the patient to accurately follow the instructions and to correctly use the inhaler.
INDICATIONS: Bronchial asthma, asthmatic bronchitis, chronic bronchitis and emphysema with a broncho - spastic component.
DOSAGE:
Adults: two puffs four to six times a day.
Children: under 12 years of age: one - two puffs two - four times a day. according to therapeutic effect.
the effect of the inhalation of Clenil Compositum Spray persists for at least four hours. No more than two puffs at a time should be employed and the treatment should not be repeated before four hours.
SIDE EFFECTS: No serious side effect has been revealed due to the use of clenil Compositum Spray at recommended doses, only some patients have complained of hoarseness. In some patients local fungal infection have appeared in the mouth and throat, they rapidly disappear with appropriate local therapy of antimycotics without interruption of treatment. Transitory side effects can appear at high dosages in some patients (moderate increase of cardiac frequency, light muscular tremor)
No comments:
Post a Comment